Immunocore Holdings plc (IMCR): Depreciation & Amortization
$3.10M
Year ended 2025-12-31
-16.4%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.10M | -26.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $4.20M | +2.4% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $4.10M | -22.6% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $5.30M | -30.3% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $7.60M | n/a | 2024-02-28, From 2021-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $3.10M | -26.2% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $24.85M | -20.9% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $8.10M | +0.6% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $16.00M | -8.3% |
| Vericel Corp (VCEL) | 2025-12-31 | $11.54M | +109.7% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $35.94M | -4.4% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Repligen Corp (RGEN) | 2025-12-31 | $78.75M | +13.0% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $1.39M | +11.5% |
Compare IMCR, TWST, ADMA, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗